Advanced Therapies Trials in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Advanced Therapies Trials in Brazil

Advanced Therapies Trials in Brazil – Clinical Trials in Latin America

The field of healthcare is continuously evolving, and advanced therapies have emerged as a promising frontier in the treatment of complex diseases. These innovative therapies, including gene therapies, cell-based treatments, and tissue engineering, offer new possibilities for patients with unmet medical needs.

In recent years, Brazil has been making significant strides in the realm of advanced therapies trials, conducting groundbreaking research that holds the potential to transform healthcare in the country. In this blog, we explore the landscape of advanced therapies trials in Brazil and shed light on their impact on patients and the healthcare system.

The Rise of Advanced Therapies

Advanced therapies represent a revolutionary approach in healthcare, focusing on the use of living cells, genetic material, and engineered tissues to treat and cure diseases. Unlike traditional treatments, advanced therapies aim to address the underlying causes of diseases, offering long-term solutions and potentially reducing the need for ongoing treatments.

With their potential applications in cancer, genetic disorders, neurodegenerative diseases, and cardiovascular conditions, advanced therapies offer hope for patients who face limited treatment options.

Brazil’s Commitment to Innovation

Brazil has recognized the transformative power of advanced therapies and has taken significant steps to promote innovation in this field.

Regulatory agencies such as the National Health Surveillance Agency (ANVISA) have established clear guidelines for the development and approval of advanced therapies, fostering an environment conducive to research and clinical trials.

Brazil’s commitment to innovation has led to collaborations with renowned researchers, pharmaceutical companies, and biotechnology firms from around the world, positioning the country as a key player in advanced therapies research.

Clinical Trials in Brazil

Brazil has become an attractive destination for advanced therapies trials due to its diverse patient population and robust research infrastructure. These trials aim to assess the safety and efficacy of novel treatments, providing Brazilian patients with early access to cutting-edge therapies.

Advanced therapies trials in Brazil encompass a wide range of therapeutic areas, including oncology, rare genetic diseases, autoimmune disorders, and regenerative medicine.

Advanced Therapies Trials in Brazil

Advanced Therapies Trials in Brazil

Advanced Therapies Trials in Brazil

Collaboration and Partnerships

The success of advanced therapies trials in Brazil is attributed, in part, to the strong collaborations and partnerships established between academia, healthcare institutions, and the private sector.

Leading Brazilian universities and research institutions, such as the University of São Paulo (USP) and the Oswaldo Cruz Foundation (Fiocruz), collaborate with industry leaders to drive research, secure funding, and establish specialized facilities for clinical trials. These collaborations foster an environment of innovation and accelerate progress in the field.

Enhanced Patient Access and Affordability

One of the significant advantages of conducting advanced therapies trials in Brazil is the potential for improved patient access and affordability. These trials offer Brazilian patients the opportunity to access novel treatments that may not be available in their home countries.

Moreover, the relatively lower healthcare costs in Brazil make advanced therapies more accessible to a broader patient population, ensuring that these groundbreaking treatments are not limited to a privileged few.

Robust Regulatory Framework and Ethical Considerations

Brazil has a robust regulatory framework in place to ensure that advanced therapies trials adhere to the highest ethical standards and prioritize patient safety. ANVISA plays a crucial role in reviewing and approving clinical trials, ensuring compliance with rigorous regulatory requirements.

Ethical considerations, such as informed consent, protection of patient privacy, and monitoring of trial progress, are prioritized to safeguard the rights and well-being of trial participants.

Challenges and Future Outlook

While Brazil has made significant progress in advancing advanced therapies trials, several challenges remain. Continued investment in research funding, development of specialized infrastructure, and capacity building are essential to further strengthen the advanced therapies landscape in Brazil.

The establishment of dedicated centers of excellence and specialized manufacturing facilities will be instrumental in supporting the translation of research findings into clinical practice.

Additionally, the implementation of sustainable reimbursement models and the integration of advanced therapies into the national healthcare system are crucial for ensuring long-term accessibility and affordability for patients.


Brazil’s commitment to advancing healthcare through advanced therapies trials is propelling the nation to the forefront of medical research. With a robust regulatory framework, strong collaborations, and a patient-centered approach, Brazil is poised to make significant contributions to the development and accessibility of advanced therapies.

These trials offer hope to patients, provide early access to groundbreaking treatments, and pave the way for a future where advanced therapies become a standard of care. Through continued innovation and collaboration, Brazil is revolutionizing healthcare for the benefit of its population and beyond.

Advanced Therapies Trials in Brazil

Source: Duke Clinical Research Institute

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Advanced Therapies Trials in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Advanced Therapies Trials in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Advanced Therapies Trials in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Advanced Therapies Trials in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Advanced Therapies Trials in Brazil

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Advanced Therapies Trials in Brazil

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Advanced Therapies Trials in Brazil

The Cohortias Team

Advanced Therapies Trials in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Advanced Therapies Trials in Brazil

Network & Partnerships